Efg Capital International Corp. Blueprint Medicines Corp Transaction History
Efg Capital International Corp.
- $432 Billion
- Q2 2023
A detailed history of Efg Capital International Corp. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Efg Capital International Corp. holds 5,500 shares of BPMC stock, worth $475,365. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,500Holding current value
$475,365% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$575 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$565 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$508 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$280 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$213 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.16B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...